Can-Fite BioPharma's total assets for Q2 2024 were $5.92M, a decrease of 0.00% from the previous quarter. CANF total liabilities were $3.44M for the fiscal quarter, a 0.00% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.